Position in PGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,838,578
+$26,515,659 QoQ
Shares Held
9,269,926
+36.3% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
5.89%
of 13F equity value
Holder Rank
#4
of 210 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Derivatives in PGEN
reported options exposure · as of Jun 30, 2026CallValue
$8,048,400
CallShares
1,412,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $91,993,189 across 32 Biotechnology names. PGEN ranks #1 (57.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
This page
|
9,269,926 | $52,838,578 | |
| 2 | QURE |
uniQure N.V.
|
197,242 | $9,084,966 | |
| 3 | ABVX |
Abivax S.A.
|
51,903 | $6,916,593 | |
| 4 | ABEO |
Abeona Therapeutics Inc.
|
755,021 | $4,666,029 | |
| 5 | ZVRA |
Zevra Therapeutics, Inc.
|
231,465 | $3,319,208 | |
| 6 | UNCY |
Unicycive Therapeutics, Inc.
|
374,132 | $1,754,679 | |
| 7 | ANAB |
Anaptysbio, Inc
|
16,868 | $1,138,590 | |
| 8 | NKTR |
Nektar Therapeutics
|
15,967 | $1,114,656 |
All Filings in PGEN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,048,400 | 1,412,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $52,838,578 | 9,269,926 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $26,322,919 | 6,801,788 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,080,560 | 3,847,024 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,205,210 | 974,228 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $475,780 | 335,057 | Shares | Defined | 2025-08-13 | |
| 2023-12-31 | $65,014 | 48,518 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||